New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
10:02 EDTUMPQ, SIG, SGEN, SLB, RDS.A, RTOKY, MATX, KKR, ITW, HFC, GOL, E, DB, CRR, BRCM, AINV, AXP, ACMPOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Access Midstream (ACMP) upgraded to Buy from Neutral at Ladenburg... American Express (AXP) upgraded at Guggenheim... Apollo Investment (AINV) upgraded to Buy from Neutral at SunTrust... Broadcom (BRCM) upgraded to Outperform from Perform at Oppenheimer... CARBO Ceramics (CRR) upgraded to Neutral from Sell at Guggenheim... Deutsche Bank (DB) upgraded to Overweight from Neutral at JPMorgan... Eni SpA (E) upgraded to Buy from Hold at Deutsche Bank... GOL Linhas (GOL) upgraded to Outperform from Market Perform at Raymond James... HollyFrontier (HFC) upgraded to Outperform at Wells Fargo... Illinois Tool Works (ITW) upgraded to Buy from Hold at Argus... KKR (KKR) upgraded to Outperform from Neutral at Credit Suisse... Matson (MATX) upgraded to Buy from Hold at BB&T... Rentokil (RTOKY) upgraded to Outperform from Neutral at Credit Suisse... Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at Deutsche Bank... Schlumberger (SLB) upgraded to Overweight from Neutral at HSBC... Seattle Genetics (SGEN) upgraded to Buy from Neutral at UBS... Signet Jewelers (SIG) resumed with an Overweight from Neutral at JPMorgan... Umpqua Holdings (UMPQ) upgraded to Equal Weight from Underweight at Barclays.
News For A;SLB;SGEN;SIG;UMPQ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
11:39 EDTAGenetic Technologies, Agilent jointly file to dimiss lawsuit
Subscribe for More Information
10:00 EDTSGENOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:49 EDTSGENSeattle Genetics upgraded to Hold from Sell at Cantor
Subscribe for More Information
October 30, 2014
16:30 EDTSGENSeattle Genetics sees FY14 revenue from ADCETRIS $172M-$177M
Seattle Genetics anticipates that 2014 revenues from ADCETRIS net product sales in the U.S. and Canada will be higher than previously anticipated, and are now expected to be in the range of $172M-$177M. The company also anticipates that 2014 collaboration revenues will be higher than previously anticipated, and are now expected to be in the range of $64M-$68M.
16:30 EDTSGENSeattle Genetics reports Q3 EPS (13c), consensus (24c)
Subscribe for More Information
October 29, 2014
16:12 EDTAAgilent reports Q3 EPS 3c, one estimate 3c
Subscribe for More Information
13:09 EDTSGENSeattle Genetics management to meet with Jefferies
Subscribe for More Information
October 28, 2014
05:57 EDTSLBStocks with implied volatility movement; SLB HPQ
Subscribe for More Information
October 27, 2014
18:38 EDTAS&P announces changes to the S&P MidCap 400 and S&P SmallCap 600 indices
Subscribe for More Information
10:52 EDTSGENSeattle Genetics, Aegerion CEOs accused of drug use in lawsuit, TheStreet says
Subscribe for More Information
October 21, 2014
08:06 EDTSIGSignet Jewelers remains a top pick at Nomura
Subscribe for More Information
October 20, 2014
11:40 EDTSIGSignet Jewelers management to meet with Sterne Agee
Group breakfast to be held in New York on October 24 hosted by Sterne Agee.
07:10 EDTAAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 17, 2014
17:50 EDTSLBSchlumberger is inexpensive and has room to rise, Barron's says
Shares of Schlumberger have fallen recently, as has the rest of the energy sector, but the stock has room to rise and is relatively inexpensive compared to its historical valuation, Barron's reports. Revenue growth was strong across the board in the third-quarter, during which several major contracts were won. The stock is also trading at close to 14.5 times analysts’ estimates for the next 12 months’ earnings, well below its historical average of 20, Barron's added. Reference Link
10:00 EDTSIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:58 EDTSLBSchlumberger sees FY15 exploration spending flat
Subscribe for More Information
08:48 EDTSLBSchlumberger sees 5c-7c EPS growth in Q4 vs. Q3
Sees Libya and Russia continuing to have an affect on earnings during Q4. Libya's Q3 activity was down 50% year over year.
08:47 EDTSLBSchlumberger sees international earnings growth in FY15
Schlumberger management stated that Russian sanctions has a 2c per share impact on Q3. The company will re-size Libyan resources and oil rigs in Iraq are slowly going back into operation. Management stated that the company did several deals for artificial lift work. The company's outlook for global GDP growth softened slightly. The company sees Brent oil prices recovering and stabilizing. Management stated that global economic recover is remains intact. The company stated that global spare oil capacity is not increasing. Management stated that 10 new deep-water rigs are scheduled for delivery in Q4. The company sees a 6% decline in deep-water drilling, primarily driven by Brazil. The company sees FY15 deep-water drilling flat. The company sees FY 14 exploration spending down 4%-5%. Comments made during Q3 earnings conference call.
05:32 EDTSIGSignet Jewelers initiated with an Overweight at Barclays
Target $120.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use